Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 408

1.

Inflammatory Bowel Disease and the Risk of Prostate Cancer.

Burns JA, Weiner AB, Catalona WJ, Li EV, Schaeffer EM, Hanauer SB, Strong S, Burns J, Hussain MHA, Kundu SD.

Eur Urol. 2018 Dec 4. pii: S0302-2838(18)30938-2. doi: 10.1016/j.eururo.2018.11.039. [Epub ahead of print]

PMID:
30528221
2.

Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis.

Colombel JF, Adedokun OJ, Gasink C, Gao LL, Cornillie FJ, D'Haens GR, Rutgeerts PJ, Reinisch W, Sandborn WJ, Hanauer SB.

Clin Gastroenterol Hepatol. 2018 Sep 26. pii: S1542-3565(18)31024-3. doi: 10.1016/j.cgh.2018.09.033. [Epub ahead of print]

3.

Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.

Hanauer SB, Sandborn WJ, Lichtenstein GR.

Gastroenterology. 2018 Sep 7. pii: S0016-5085(18)34933-3. doi: 10.1053/j.gastro.2018.08.043. [Epub ahead of print]

PMID:
30195449
4.

Improving IBD Care: A Personalized Approach to Management.

Hanauer SB.

Gastroenterol Hepatol (N Y). 2018 Mar;14(3):1-20. No abstract available.

5.

Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.

Sandborn WJ, Rutgeerts P, Gasink C, Jacobstein D, Zou B, Johanns J, Sands BE, Hanauer SB, Targan S, Ghosh S, de Villiers WJS, Colombel JF, Feagan BG.

Aliment Pharmacol Ther. 2018 Jul;48(1):65-77. doi: 10.1111/apt.14794. Epub 2018 May 24.

6.

Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia.

Krugliak Cleveland N, Ollech JE, Colman RJ, Rodriquez D, Hirsch A, Cohen RD, Hanauer SB, Hart J, Hurst R, Rubin DT.

Clin Gastroenterol Hepatol. 2018 May 8. pii: S1542-3565(18)30467-1. doi: 10.1016/j.cgh.2018.04.061. [Epub ahead of print] No abstract available.

PMID:
29751167
7.

Real-time Interobserver Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn's Disease: An International Multicenter Study.

Calabrese E, Kucharzik T, Maaser C, Maconi G, Strobel D, Wilson SR, Zorzi F, Novak KL, Bruining DH, Iacucci M, Watanabe M, Lolli E, Chiaramonte C, Hanauer SB, Panaccione R, Pallone F, Ghosh S, Monteleone G.

Inflamm Bowel Dis. 2018 Apr 28. doi: 10.1093/ibd/izy091. [Epub ahead of print]

PMID:
29718450
8.

Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.

Patel P, Yarur A, Dalal S, Sakuraba A, Rubin DT, Hanauer SB, Hanan I, Raffals LH, Cohen RD, Pekow J.

Inflamm Bowel Dis. 2018 May 18;24(6):1291-1297. doi: 10.1093/ibd/izx105.

PMID:
29506124
9.

Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).

Friedman AB, Brown SJ, Bampton P, Barclay ML, Chung A, Macrae FA, McKenzie J, Reynolds J, Gibson PR, Hanauer SB, Sparrow MP.

Aliment Pharmacol Ther. 2018 Apr;47(8):1092-1102. doi: 10.1111/apt.14571. Epub 2018 Feb 21.

PMID:
29468701
10.

Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?

Papamichael K, Osterman MT, Siegel CA, Melmed GY, Dubinsky MC, Colombel JF, Hanauer SB, Cheifetz AS.

Gastroenterology. 2018 Mar;154(4):1201-1202. doi: 10.1053/j.gastro.2018.01.001. Epub 2018 Feb 10. No abstract available.

PMID:
29432749
11.

Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.

Adedokun OJ, Xu Z, Gasink C, Jacobstein D, Szapary P, Johanns J, Gao LL, Davis HM, Hanauer SB, Feagan BG, Ghosh S, Sandborn WJ.

Gastroenterology. 2018 May;154(6):1660-1671. doi: 10.1053/j.gastro.2018.01.043. Epub 2018 Feb 1.

12.

A Never Ending STORI.

Hanauer SB.

Clin Gastroenterol Hepatol. 2018 Jul;16(7):1034-1036. doi: 10.1016/j.cgh.2018.01.039. Epub 2018 Jan 31. No abstract available.

PMID:
29391270
13.

Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease.

Krugliak Cleveland N, Huo D, Sadiq F, Sofia MA, Marks J, Cohen RD, Hanauer SB, Turner J, Hart J, Rubin DT.

Gastrointest Endosc. 2018 May;87(5):1304-1309. doi: 10.1016/j.gie.2017.12.016. Epub 2018 Jan 4.

PMID:
29307473
14.

Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis.

Colombel JF, Sandborn WJ, Reinisch W, Peyrin-Biroulet L, Panaccione R, Rutgeerts P, Hanauer SB, Ghosh S, Van Assche G, Robinson AM, Lau W, Maa JF, Huang B, Pappalardo B, Read H.

Aliment Pharmacol Ther. 2018 Jan;47(2):219-228. doi: 10.1111/apt.14420. Epub 2017 Nov 21.

PMID:
29159817
15.

Targeting Crohn's disease.

Hanauer SB.

Lancet. 2018 Dec 23;390(10114):2742-2744. doi: 10.1016/S0140-6736(17)32754-X. Epub 2017 Oct 31. No abstract available.

PMID:
29096947
16.

Combination Therapy for Inflammatory Bowel Disease.

Hanauer SB.

Gastroenterol Hepatol (N Y). 2017 May;13(5):296-298. No abstract available.

17.

miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.

Pekow J, Hutchison AL, Meckel K, Harrington K, Deng Z, Talasila N, Rubin DT, Hanauer SB, Hurst R, Umanskiy K, Fichera A, Hart J, Dinner AR, Bissonnette M.

Inflamm Bowel Dis. 2017 Aug;23(8):1328-1337. doi: 10.1097/MIB.0000000000001104.

18.

A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity.

Bhattacharyya S, Shumard T, Xie H, Dodda A, Varady KA, Feferman L, Halline AG, Goldstein JL, Hanauer SB, Tobacman JK.

Nutr Healthy Aging. 2017 Mar 31;4(2):181-192. doi: 10.3233/NHA-170023.

19.

Targeting interleukin 23 for Crohn's disease: finding the right drug for the right patient.

Hanauer SB.

Lancet. 2017 Apr 29;389(10080):1671-1672. doi: 10.1016/S0140-6736(17)30977-7. Epub 2017 Apr 12. No abstract available.

PMID:
28411871
20.

The Influence of Methotrexate Treatment on Male Fertility and Pregnancy Outcome After Paternal Exposure.

Grosen A, Kelsen J, Hvas CL, Bellaguarda E, Hanauer SB.

Inflamm Bowel Dis. 2017 Apr;23(4):561-569. doi: 10.1097/MIB.0000000000001064. Review.

PMID:
28267049

Supplemental Content

Loading ...
Support Center